Canada Agrees to Pay for Unused Covid Shots, Prompting Jump in Novavax Stock

Nikos Pekiaridis | Nurphoto | Getty Images Stock Chart Icon Stock chart icon Novavax shares jump on news of a settlement payment from the Canadian government. Uncertainty surrounds the number of doses of Novavax’s vaccine, its only commercially available product after 35 years, that were left unused. The amended agreement stipulates that Novavax will provide …

Read more

Moderna Seeks FDA Approval for Enhanced Covid Vaccine Targeting Fall Season

A vial and a medical syringe seen displayed in front of the U.S. Food and Drug Administration and Moderna biotechnology company’s logos. Pavlo Gonchar | LightRocket | Getty Images Moderna has officially submitted its updated Covid vaccine for FDA approval. The biotech company is targeting the omicron subvariant XBB.1.5, which is currently the dominant strain …

Read more

CDC Panel Advises Adults Over 60 to Choose Pfizer and GSK Vaccines

A healthcare professional in Los Angeles prepares a flu vaccine shot for a local resident. Xinhua News Agency | Getty Images A committee advising the Centers for Disease Control and Prevention (CDC) has recommended that adults aged 60 and above consult their doctors and receive a single dose of RSV vaccines from Pfizer and GSK. …

Read more

Long-term Protection Offered by GSK’s RSV Vaccine for Older Adults

Exciting Advances in Respiratory Syncytial Virus Vaccine Research Image Source: Hailshadow | Istock | Getty Images – GlaxoSmithKline announced today that their respiratory syncytial virus (RSV) vaccine for adults aged 60 and older has proven effective over two RSV seasons. According to recent data from a phase three clinical trial, a single dose of the …

Read more

Omicron subvariant XBB.1.5 should be the focus of Covid shots this autumn.

> XBB.1.5 strain of Covid CFOTO | Future Publishing | Getty Images The U.S. Food and Drug Administration (FDA) has released a recommendation for Covid vaccine manufacturers to develop single-strain shots for the fall that specifically target the omicron subvariant XBB.1.5. This strain is currently the dominant variant of the virus nationwide. In their official …

Read more

Reps for Foxx Deny Authenticity of Vax Claim, Yet Its Persistence Persists

The details surrounding Jamie Foxx’s health remain mostly unknown, despite a positive update from his daughter. However, one thing that can now be ruled out is that he experienced medical complications from the COVID vaccine. Representatives for the 55-year-old actor have clarified in an email to NBC News that reports suggesting Foxx was left …

Read more

FDA advisors recommend targeting XBB variant with Covid vaccines this fall.

A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters The U.S. Food and Drug Administration’s independent panel of advisors on Thursday recommended updating Covid shots for the fall and winter to target one specific variant – the …

Read more

The Arduous Road Ahead for Novavax’s Survival

In this illustration photo taken in Krakow, Poland on December 2, 2021, medical syringes and the Novavax logo are prominently displayed in the background. Novavax, a cash-strapped Covid vaccine maker, is confident about its ability to survive and thrive. The Maryland-based company recently announced its first-quarter financial results, which included a cost-cutting initiative and a …

Read more